Cart summary

You have no items in your shopping cart.

LY-411575

SKU: orb1225693

Description

A potent γ-secretase inhibitor that has an IC50 value of 119 pM for reduction of Aβ levels in APP-transfected cell lines; dose dependently reduces Aβ(1-40) and Aβ(1-42) in the brain, CSF, and plasma of Tg2576 mice; reduces cortical Abeta(40) in young transgenic CRND8 mice with ED50 of 0.6 mg/kg, and produces significant thymus atrophy and intestinal goblet cell hyperplasia at higher doses (>3 mg/kg).Alzheimer's Disease Preclinical.

Images & Validation

Key Properties

CAS Number209984-57-6
MW479.4753
Purity>98% (HPLC)
FormulaC26H23F2N3O4
SMILESC[C@@H](C(N[C@H]1C2=CC=CC=C2C3=CC=CC=C3N(C)C1=O)=O)NC([C@H](C4=CC(F)=CC(F)=C4)O)=O
Targetγ-secretase
Solubility10 mM in DMSO

Bioactivity

In Vivo
LY-411, 575 (10 mg/kg) decreases brain and plasma Aβ40 and-42 robustly when chronically administered to TgCRND8 mice. LY411, 575 reduces cortical Aβ40 in young transgenic CRND8 mice (ED50 appr 0.6 mg/kg) and produces significant thymus atrophy and intestinal goblet cell hyperplasia at higher doses (>3 mg/kg). The extent of intestinal goblet cell hyperplasia induced by LY411, 575 (10 mg/kg) is similar in young and aged mice. LY411575 inhibits mouse proliferative vitreoretinopathy (PVR) formation In vivo.
In Vitro
LY-411, 575 blocks Notch activation, and results in apoptosis in primary and immortalized KS cells. LY-411, 575 (500 μM) induces G2/M growth arrest SLK cells. LY411575 treatment significantly decreases the amounts of intracellular HCV RNA with IC50 of 0.56 ± 0.20 μM and extracellular HCV particles. LY411575 (0-40 nM) alone or in combination with BMS-790052 (0-40 pM) decreases supernatant infectious titers in a dose-dependent manner, and is synergistic regarding production of infectious virus. LY411575 (10 μM) treatment impairs ROS production in HCVcc-infected cells. LY411575 significantly attenuates EMT by inhibiting the Notch signaling activation in vitro.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

LY411575 | LY 411575

Similar Products

  • LY-411575 isomer 3 [orb1709226]

    479.48

    C26H23F2N3O4

    100 mg, 50 mg, 25 mg
  • LY-411575 isomer 2 [orb1709227]

    479.48

    C26H23F2N3O4

    50 mg, 25 mg, 100 mg
  • LY-411575 isomer 1 [orb1709228]

    209984-58-7

    479.48

    C26H23F2N3O4

    50 mg, 100 mg, 25 mg
  • LY-411575 [orb1301106]

    99.23%

    209984-57-6

    479.48

    C26H23F2N3O4

    5 mg, 10 mg, 25 mg, 1 ml x 10 mM (in DMSO), 50 mg, 100 mg, 2 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

LY-411575 (orb1225693)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

200 mg
500 mg
2 mg
$ 80.00
5 mg
$ 110.00
10 mg
$ 170.00
25 mg
$ 320.00
50 mg
$ 580.00
100 mg
$ 850.00